Director dealings: Collagen chairman puts more skin in game
Collagen Solutions chairman David Evans put more skin in the game on Monday as the company revealed annual losses had tightened up thanks to a plumped-up top line.
Collagen Solutions
6.62p
16:55 16/11/20
FTSE AIM All-Share
728.53
08:25 14/11/24
Health Care Equipment & Services
10,240.67
08:24 14/11/24
Serial entrepreneur and small company backer Evans took his stake in the company up to 8.6% by snapping up 900,000 shares in the AIM-listed company at a price of 6p apiece.
Evans, who is also chairman of Omega Diagnostics, OptiBiotix Health and Premaitha Health, earlier in the day reported on a glowing set of full year results that showed revenue and other income for the year ending 31 March up 213% to £3.2m thanks in large part to newly acquired Southern Lights Biomaterials.
Losses before interest tax and depreciation and amortisation (LBITDA) decreased 40.6% to £410,016 and the loss per share halved to 0.57p.
Evans said Collagen Solutions had made a positive start to the current financial year and he was "emboldened by the knowledge that the positive benefits of having 'sticky' revenues from embedded products will ensure about 70% of the group's ongoing revenues are already, in effect, secured".
He said the main challenges were to win new customers and execute the pipeline in a timely manner, with investment in personnel already made to achieve this.
"Additionally, we are looking to successfully execute our R&D pipeline where the investment that we have made, and continue to make, begins to produce cash flow."
The recent investment in the ChondroMimetic platform, he added, "represents a significant value creating opportunity but to deliver this we need to be smart about how we execute our plan to ensure we are not putting at risk shareholder value".
Shares in the company, having hit their lowest level of 5p since they were floated in 2013, were up 29% to 6.75p not long before the close of play on Monday.
Top Director Buys
Collagen Solutions (COS)
Director name: Evans,David
Amount purchased: 900,000 @ 6.00p
Value: £54,000.00
President Energy (PPC)
Director name: Levine,Peter M
Amount purchased: 503,750 @ 7.47p
Value: £37,615.01
Mckay Securities (MCKS)
Director name: Grainger,Richard
Amount purchased: 15,000 @ 165.00p
Value: £24,750.00
Mckay Securities (MCKS)
Director name: Austen,Jon
Amount purchased: 10,000 @ 170.00p
Value: £17,000.00
Character Group (CCT)
Director name: Harris,David
Amount purchased: 3,000 @ 440.00p
Value: £13,200.00
Advanced Oncotherapy (AVO)
Director name: Bradfield ,Michael
Amount purchased: 10,000 @ 119.50p
Value: £11,950.00
Sirius Real Estate Ltd. (SRE)
Director name: Sachdev,Nilesh (Neil)
Amount purchased: 23,137 @ € 0.51
Value: € 11,684.18
Zegona Communications (ZEG)
Director name: Kalika,Howard
Amount purchased: 8,771 @ 113.76p
Value: £9,977.89
Diageo (DGE)
Director name: Humer,Franz B
Amount purchased: 383 @ 2,164.00p
Value: £8,288.12
Immunodiagnostic Systems Holdings (IDH)
Director name: Kaspar,Klaus Peter
Amount purchased: 4,100 @ 142.00p
Value: £5,822.00
Rolls-royce Holdings (RR.)
Director name: Chapman,Frank
Amount purchased: 558 @ 709.00p
Value: £3,956.22
Rolls-royce Holdings (RR.)
Director name: Davis ,Ian
Amount purchased: 279 @ 709.00p
Value: £1,978.11
Rolls-royce Holdings (RR.)
Director name: Cairnie ,Ruth
Amount purchased: 273 @ 709.00p
Value: £1,935.57
Baillie Gifford Shin Nippon (BGS)
Director name: Donaldson,Michael Neil
Amount purchased: 256 @ 582.00p
Value: £1,489.92
Rolls-royce Holdings (RR.)
Director name: Yang,Lee Hsien
Amount purchased: 139 @ 709.00p
Value: £985.51
Rolls-royce Holdings (RR.)
Director name: McAdam,John
Amount purchased: 33 @ 709.00p
Value: £233.97
Prudential (PRU)
Director name: Wells,Mike
Amount purchased: 17 @ 1,199.50p
Value: £203.91
Diageo (DGE)
Director name: Mikells,Kathryn
Amount purchased: 9 @ 2,164.00p
Value: £194.76
Enterprise Inns (ETI)
Director name: Maloney,David
Amount purchased: 25,000 @ 0.78p
Value: £194.00
Prudential (PRU)
Director name: Foley,John W.
Amount purchased: 16 @ 1,199.50p
Value: £191.92
Prudential (PRU)
Director name: Nicandrou,Nicolaos
Amount purchased: 15 @ 1,199.50p
Value: £179.92
Rolls-royce Holdings (RR.)
Director name: Smith,David
Amount purchased: 21 @ 719.90p
Value: £151.18
Taylor Wimpey (TW.)
Director name: Jordan,James J
Amount purchased: 123 @ 122.10p
Value: £150.18
Taylor Wimpey (TW.)
Director name: Redfern,Peter
Amount purchased: 122 @ 122.10p
Value: £148.96
Ssp Group (SSPG)
Director name: Davies,Jonathan
Amount purchased: 45 @ 277.80p
Value: £125.01
Ssp Group (SSPG)
Director name: Swann,Kate
Amount purchased: 45 @ 277.80p
Value: £125.01
Rolls-royce Holdings (RR.)
Director name: Smith,Colin P
Amount purchased: 17 @ 719.90p
Value: £122.38
Primary Health Properties (PHP)
Director name: Hyman,Harry Abraham
Amount purchased: 90 @ 108.24p
Value: £97.42
Primary Health Properties (PHP)
Director name: Hyman,Harry Abraham
Amount purchased: 90 @ 108.24p
Value: £97.42
Top Director Sells
Severfield (SFR)
Director name: Cochrane,Ian
Amount purchased: 132,113 @ 43.70p
Value: £57,726.78
Severfield (SFR)
Director name: Dunsmore,Alan
Amount purchased: 108,644 @ 43.70p
Value: £47,472.00